Table of Contents:
PharmaNutra’s financial results in 2024
PharmaNutra recorded a significant increase in revenues and profitability in the first nine months of 2024, confirming its leading position in the sector. Sales revenues reached 83.5 million euros, an increase of 17% compared to the same period of the previous year. This result not only highlights the company’s strength, but also its ability to adapt and thrive in a
competitive market.
Growing operating margins and net results
PharmaNutra’s gross operating profit rose to 24.2 million euros, an improvement of 27.2%. In addition, the net result showed an increase of 35.3%, reaching 13.2 million euros. These figures are particularly significant, as they demonstrate not only revenue growth, but also operational efficiency that is leading to increasingly positive results
.
Strategic investments and future prospects
Roberto Lacorte, vice president of PharmaNutra, commented on the results, stating that this is a confirmation of the company’s continuous growth. “These results, normally considered exceptional, are tangible proof of the strategic investments we have made over the years,” said Lacorte. The company’s net financial position is positive by 0.5 million euros, which suggests prudent and forward-looking management
of resources.
Movements on the stock market
Recently, Assurazioni Generali announced the purchase of more than 1.8 million treasury shares, strengthening its position on the stock market. This movement led the company to hold 2.82% of its share capital, thus contributing to an increase in the share price, which reached 25.55 euros.
Outlook for 2024
The board of directors of RCS approved the financial data for the first nine months of 2024, showing a growing net profit and an improvement in EBITDA. The company expects to maintain positive margins also in 2024, which is an encouraging sign for investors and for the market in general
.
Acquisitions and market strategies
The European Commission recently gave the green light to the joint acquisition of Grandi Stazioni Retail by Omers Infrastructure European Holdings and DWS Group. This operation, focused on the management of commercial and advertising spaces in Italian railway stations, does not raise competition concerns, suggesting a favorable environment for
further investments in the sector.
Share repurchase programs
BPER Banca has launched a share repurchase program, which began on November 11, to support the free assignment of shares to the group’s employees. This plan aims to encourage staff and strengthen investor confidence, covering various incentive plans. Equita Sim will manage the program independently, ensuring efficient resource management
.